Target intelligence / Profile preview

Daboia siamensis venom serine protease (DsSVSP)

Target
DsSVSP
Molecular classification
Enzyme, Serine protease, Hydrolase, S1 peptidase family
01

Overview

Daboia siamensis venom serine proteases (SVSPs) are a major family of enzymatic toxins found in the venom of the Eastern Russell's viper, a medically significant species in Southeast Asia and parts of East Asia. These enzymes primarily disrupt the host's hemostatic system by mimicking or activating key components of the coagulation cascade. The most prominent member, Factor V activator (RVV-V), specifically cleaves and activates coagulation Factor V, leading to rapid, uncontrolled thrombin generation. Other SVSPs include thrombin-like enzymes and fibrinogenases that directly degrade fibrinogen, resulting in the formation of unstable fibrin clots and the depletion of clotting factors. This process culminates in venom-induced consumptive coagulopathy (VICC), a life-threatening condition characterized by systemic hemorrhage and potential organ failure, such as acute kidney injury. In a clinical setting, these proteases are the primary targets for neutralization by specific monovalent and polyvalent antivenoms, which bind to the toxins and inhibit their enzymatic activity. Beyond their role in envenomation, SVSPs are studied as biochemical tools and templates for developing novel anticoagulant and procoagulant therapeutics due to their high substrate specificity.

Other names
Eastern Russell's viper venom serine proteaseSnake venom serine proteaseRussell's viper venom serine proteinaseRVV-VFactor V activatorThrombin-like enzymeFibrinogenase
02

Mechanism of action

Neutralization of enzymatic activity through antibody-mediated binding, which prevents the activation of coagulation factors (such as Factor V) and the degradation of fibrinogen, thereby halting the progression of consumptive coagulopathy.

03

Biological functions

Blood coagulationFibrinolysisHemostasisProteolysis
04

Disease associations

Snakebite envenomationConsumptive coagulopathyHemorrhageAcute kidney injury
05

Safety considerations

Venom-induced consumptive coagulopathy (VICC)Systemic hemorrhageAcute kidney injury (AKI)Antivenom-induced anaphylaxisSerum sickness
06

Interacting drugs

Daboia siamensis Monovalent Antivenom

2 more in the full profile.

07

Biomarkers

Prothrombin time (PT)Activated partial thromboplastin time (aPTT)Fibrinogen levelsFactor V levels20-minute whole blood clotting test (WBCT20)Venom antigen levels

Beyond the preview

Go deeper on Daboia siamensis venom serine protease (DsSVSP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia siamensis venom serine protease (DsSVSP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call